Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report

References

• Szablewski V, Dereure O, Rene C, et al. Cutaneous localization of angioimmunoblastic T-cell lymphoma may masquerade as B-cell lymphoma or classical Hodgkin lymphoma: a histologic diagnostic pitfall. J Cutan Pathol. 2019;46(2):102–110. doi:10.1111/cup.13382
   PubMed Web of Science ®Google Scholar
• Ellis C, Ramirez J, LaFond AA. Angioimmunoblastic T-cell lymphoma mimicking diffuse large B-cell lymphoma. Cutis. 2018;102(3):179–182.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Maruyama R, Mishima S, et al. Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. J Clin Exp Hematop. 2010;50(1):59–63. doi:10.3960/jslrt.50.59
   PubMedGoogle Scholar
• Zhou Y, Xu Z, Lin W, et al. Comprehensive genomic profiling of EBV-positive diffuse large B-cell lymphoma and the expression and clinicopathological correlations of some related genes. Front Oncol. 2019;9:683. doi:10.3389/fonc.2019.00683
   PubMed Web of Science ®Google Scholar
• Poon F, Ieremia E, Collins G, Matin RN. Epstein-Barr virus-induced cutaneous diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. Am J Dermatopathol. 2019;41(12):927–930. doi:10.1097/DAD.0000000000001371
   PubMed Web of Science ®Google Scholar
• Hong R, Sheng L, Ouyang G. Composite angioimmunoblastic T cell/diffuse large B-cell lymphoma treated with reduced-intensity conditioning HLA-haploidentical allo-HSCT: a case report and review of the literature. Int J Clin Exp Pathol. 2018;11(11):5473–5480.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Rosenblum MK, Dogan A, Jungbluth AA, Chiu A. Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma. J Hematop. 2015;8(4):235–241. doi:10.1007/s12308-015-0241-8
   PubMed Web of Science ®Google Scholar
• Yamshon S, Ruan J. IMiDs New and Old. Curr Hematol Malig Rep. 2019;14(5):414–425. doi:10.1007/s11899-019-00536-6
   PubMed Web of Science ®Google Scholar
• Zhang C, Yi Y, Chen C, Wang J, Liu Z. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report. Diagn Pathol. 2015;10(1):215. doi:10.1186/s13000-015-0450-6
   PubMedGoogle Scholar
• de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2010;148(5):673–689. doi:10.1111/j.1365-2141.2009.08003.x
   PubMed Web of Science ®Google Scholar
• Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017;129(9):1095–1102. doi:10.1182/blood-2016-09-692541
   PubMed Web of Science ®Google Scholar
• Mhaidly R, Krug A, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E. New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP. Oncogenesis. 2020;9(8):73. doi:10.1038/s41389-020-00259-x
   PubMed Web of Science ®Google Scholar
• Eivazi S, Bagheri S, Hashemzadeh MS, et al. Development of T follicular helper cells and their role in disease and immune system. Biomed Pharmacother. 2016;84:1668–1678.
   PubMed Web of Science ®Google Scholar
• Huang J, Zhang PH, Gao YH, Qiu LG. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. Diagn Cytopathol. 2012;40(4):346–351. doi:10.1002/dc.21641
   PubMed Web of Science ®Google Scholar
• Mosalpuria K, Bociek RG, Vose JM. Angioimmunoblastic T-cell lymphoma management. Semin Hematol. 2014;51(1):52–58. doi:10.1053/j.seminhematol.2013.11.008
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie B, Chen Y, Huang Z, Tan H. Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature. Int J Clin Exp Pathol. 2014;7(6):3432–3438.
   PubMed Web of Science ®Google Scholar
• Alruwaii ZI, Montgomery EA. Select Epstein-Barr virus-associated digestive tract lesions for the practicing pathologist. Arch Pathol Lab Med. 2020. doi:10.5858/arpa.2019-0703-RA
   Web of Science ®Google Scholar
• Garciaz S, Coso D, Schiano de Colella JM, Bouabdallah R. Lenalidomide for the treatment of B-cell lymphoma. Expert Opin Investig Drugs. 2016;25(9):1103–1116. doi:10.1080/13543784.2016.1208170
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou S, Palmisano M. Clinical pharmacokinetics and pharmacodynamics of lenalidomide. Clin Pharmacokinet. 2017;56(2):139–152. doi:10.1007/s40262-016-0432-1
   PubMed Web of Science ®Google Scholar
• Witzig TE, Nowakowski GS, Habermann TM, et al. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. Ann Oncol. 2015;26(8):1667–1677. doi:10.1093/annonc/mdv102
   PubMed Web of Science ®Google Scholar
• Gribben JG, Fowler N, Morschhauser F. Mechanisms of action of lenalidomide in B-cell non-Hodgkin lymphoma. J Clin Oncol. 2015;33(25):2803–2811. doi:10.1200/JCO.2014.59.5363
   PubMed Web of Science ®Google Scholar
• Miao Y, Medeiros LJ, Li Y, Li J, Young KH. Genetic alterations and their clinical implications in DLBCL. Nat Rev Clin Oncol. 2019;16(10):634–652.
   PubMed Web of Science ®Google Scholar
• Jones RJ, Iempridee T, Wang X, et al. Lenalidomide, thalidomide, and pomalidomide reactivate the Epstein-Barr virus lytic cycle through phosphoinositide 3-kinase signaling and Ikaros expression. Clin Cancer Res. 2016;22(19):4901–4912. doi:10.1158/1078-0432.CCR-15-2242
   PubMed Web of Science ®Google Scholar
• Ngeow JYY, Quek RHH, Ng DCE, et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann Oncol. 2009;20(9):1543–1547. doi:10.1093/annonc/mdp030
   PubMed Web of Science ®Google Scholar
• Giraudo C, Karanikas G, Weber M, et al. Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging. J Magn Reson Imaging. 2018;47(5):1217–1226. doi:10.1002/jmri.25884
   PubMed Web of Science ®Google Scholar
• Mir F, Barrington SF, Brown H, et al. Baseline SUVmax did not predict histological transformation in follicular lymphoma in the Phase 3 GALLIUM study. Blood. 2020;135(15):1214–1218. doi:10.1182/blood.2019001091
   PubMed Web of Science ®Google Scholar
• Na SJ, Park HL, Lee SY, Song KY, Kim SH. Correlation between infection status of Epstein-Barr virus and (18)F-fluorodeoxyglucose uptake in patients with advanced gastric cancer. In Vivo. 2017;31(4):749–753.
   PubMed Web of Science ®Google Scholar
• Sun JN, Tan YH, Li YY, et al. [Discordant lymphoma consisting of angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(9):777. Chinese.
   PubMedGoogle Scholar